Federal Register notice: FDA posts a draft guidance with information for sponsors who are developing certain local anesthetic drug products to produce...
Federal Register notice: FDA makes available a final guidance entitled The Use of Published Literature in Support of New Animal Drug Approvals.
FDA approves a Telix Pharmaceuticals supplemental NDA for Illuccix and its use in selecting prostate cancer patients for whom Novartis Pluvicto is ind...
FDA clears the BD Vaginal Panel running on the BD COR System to detect the three most common causes of vaginitis.
GlaxoSmithKline says its meningococcal MenABCWY vaccine candidate met all 11 primary endpoints in a pivotal Phase 3 trial.
FDA publishes an International Pharmaceutical Regulators Program reflection paper addressing general considerations for using raw materials in the man...
The Senate Appropriations Committee announces a 4/19 subcommittee hearing to review FDAs fiscal year 2024 budget request.
An FDA Advisory Committee votes 16 to 1 that Pfizers Paxlovid (nirmatrelvir and ritonavir) has a favorable benefit-risk profile for treating mild-to-m...